Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors

Bioconjugate Chemistry

Volumn 7, Issue 1, 1996, Pages 7-15

  Capala, Jacek ^a,e   Barth, Rolf F ^a   Bendayan, Moïse ^b   Lauzon, Michel ^b   Adams, Dianne M ^a   Soloway, Albert H ^a   Fenstermaker, Robert A ^c   Carlsson, Jörgen ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMS; BORON; BRAIN; CELL MEMBRANES; TUMORS;

B ATOMS; BIOCONJUGATES; BORON NEUTRON CAPTURE THERAPY; BORON NEUTRONCAPTURE THERAPY; BRAIN TUMORS; CANCER CELLS; EPIDERMAL GROWTH FACTOR RECEPTORS; EPIDERMAL GROWTH FACTORS; STARBURSTS; THIOL GROUPS;

BIOMOLECULES; TUMORS;

EID: 0030038708     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc950077q     Document Type: Article

References (69)

1. Aakwaag, S., Utaaker, E., Lea, O. A., and Lahooti, H. (1990) Growth Control of Human Mammary Cancer Cells (MCF-7 Cells) in Culture: Effect of Estradiol and Growth Factors in Serum-containing Medium. Cancer Res. 50, 7806-7810.
2. Alam, F., Barth, R. F., and Soloway, A. H. (1989) Boron Containing Immunoconjugates for Neutron Capture Therapy and for Immunocytochemistry. Antibody, Immunoconjugates, Radiopharm. 2, 145-163.
3. Allen, B. J., Moore, D. E., and Harrington, B. V., Eds. (1992) Progress in Neutron Capture Therapy for Canter, Plenum Press, New York and London.
4. 131I Conjugates on the Clonogenic Survival of Cultured Glioma Cells. J. Neuro-Oncology 14, 213-223.
5. Barth, R. F. (1996) Biologic Considerations in Targeting Brain Tumors for Boron Neutron Capture Therapy. Cancer Boron Neutron Capture Therapy (Y. Mishima, Ed.), Plenum Press, New York (in press).
6. Barth, R. F., Adams, D. M., Soloway, A. H., Mechetner, E. B., Alam, F., and Anisuzzaman, A. K. M. (1991) Determination of Boron in Tissues and Cells Using Direct-Current Plasma Atomic Emission Spectroscopy. Anal. Chem. 63, 890-893.
7. Barth, R. F., Soloway, A. H., Fairchild, R. G., and Brugger, R. M. (1992) Boron Neutron Capture Therapy for Cancer. Realities and Prospects. Cancer 70, 2995-3007.
8. Barth, R. F., Adams, D., Soloway, A. H., Alam, F., and Darby, M. V. (1994) Boronated Starburst Dendrimer-Monoclonal Antibody Immunoconjugates: Evaluation as a Potential Delivery System for Neutron Capture Therapy. Bioconjugate Chem. 5, 58-66.
9. Bendayan, M., Barth, R. F., Gingras, D., Londoňo, I., Robinson, P. T., Alam, F., Adams, D. M., and Mattiazzi, L. (1989) Electron Spectroscopic Imaging for High-resolution Immunocytochemistry: Use of Boronated Protein A. J. Histochem. Cytochem. 37, 573-580.
10. Bidlingmeyer, B. A., Cohen, S. A., and Tarvin, T. L. (1984) Rapid Analysis of Amino Acids Using Pre-column Derivatization. J. Chromatogr. 336, 93-104.
11. Bigner, S, H., Humphrey, P. A., Wong, A. J., Vogelsein, B. Mark, J., Friedman, H. S., and Bigner, D. D. (1990) Characterization of the Epidermal Growth Factor Receptor in Human Glioma Cell Lines and Xenografts. Cancer Res. 50, 8017-8022.
12. Bradwell, A. R., Fairweather, D. S., Dykes, P. W., Keeling, A., Vaughan, A., and Taylor, J. (1985) Limiting factors in the Localization of Tumours with Radiolabeled Antibodies. Immunol. Today 6, 163-170.
13. Brem, H., Mahaley, M. S., Jr., Vick, N. A., Black, K. L., Schold, S. C., Jr., Burger, P. C., Friedman, A. H., Ciric, I. S., Eller, T. W., Cozzenes, J. W., and Kenealy, J. N. (1991) Interstitial Chemotherapy with Drug Polymer Implants for the Treatment of Recurrent Gliomas. J. Neurosurg. 74, 441-446.
14. Brightman, M. W. (1989) The Anatomic Basis of the Blood-Brain Barrier. Implications of the Blood-Brain Barrier and Its Manipulation (E. A. Neuwelt, Ed.) Vol. 1, pp 53-83, Plenum Publishing Corp., New York.
15. 131U-EGF. Studies on Cultured Glioma Cells. Int. J. Rod. Biol. 60, 497-510.
16. 131I-EGF on Cultured Human Glioma Cells. J. Neuro-Oncol, 9, 201-210.
17. 10B to Malignant Gliomas. Advances of Neutron capture Therapy (A. H. Soloway, R. F. Barth, and D. E. Carpenter, Eds.) pp 371-375, Plenum Press, New York.
18. Carlsson, J., Gedda, L., Grönvik, C., Hartman, T., Lindström, A., Lindström, P., Lundqvist, H., Lövqvist, A., Malmqvist, J., Olsson, P., Essand, M., Pontèn, J., Sjöberg, S., and Westermark, B. (1994) Strategy for Boron Neutron Capture Therapy Against Tumor Cells with Over-Expression of the Epidermal Growth Factor-Receptor. Int. J. Radiat. Oncol. Biol. Phys. 30, 105-115.
19. Carpenter, G. (1987) Receptors for Epidermal Growth Factor and Other Polypeptide Mitogens. Ann. Rev. Biochem. 56, 881-914.
20. 125I-Labelled Epidermal Growth Factor. Binding, Internalization, and Degradation in Human Fibroblasts. J. Cell Biol. 71, 159-171.
21. Carpenter, G., and Cohen, S. (1979) Epidermal Growth Factor. Ann. Rev. Biochem. 48, 193-216.
22. Cohen, S. A., Tarvin, T. L., and Bidlingmeyer, B. A. (1987) Amino Acid Analysis Using Pre-column Derivatization With Phenylisothiocyanate: Matrix Effects and Tryptophan Analysis. Proteins: Structure and Function (J. J. L'Italien, Ed.) pp 207-213, Plenum Press, New York.
23. Downward, J., Yarden, Y., Mayes, E., Scare, G., Totty, P., Stockwell, A., Ullrich, A., Schlessinger, J., and Waterfield, M. D. (1984) Close Similarity of Epidermal Growth Factor Receptor and v-erb-B Oncogene Protein Sequences. Nature 307, 521-527.
24. Ekstrand, A. J., James, C. D., Cavenee, W. K., Selinger, B., Petterson, R. E., and Collins, V. P. (1991) Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo. Cancer Res. 51, 521-527.
25. Epenetos, A. A., Courtney-Luck, N., Pickering, D., Hooker, G., Durbin, H., Lavender, J. P., and McKenzie, C. G. (1965) Antibody Guided Irradiation of Brain Glioma By Arterial Infusion of Radioactive Monoclonal Antibody Against Epidermal Growth Factor Receptor and Blood Group A Antigen. Br. Med. J. 290, 1463-1466.
26. Fenstermaker, R. A., Capala, J., Barth, R. F., Hujer, A., Kung, H.-J., and Kaetzer, D. M., Jr. (1995) The Effect of Epidermal Growth Factor Receptors (EGFR) Expression on in Vivo Growth of Rat C6 Glioma Cells. Leukemia 9 (Suppl. 1), S106-S112.
27. Flanagan, T. R., Emerich, D. F., and Winn, S. R., Eds. (1994) Providing Pharmacological Access to the Brain. Methods in Neurosciences, Vol. 21, Academic Press, Inc., New York.
28. Gabel, D., and Moss, R., Eds. (1992) Boron neutron Capture Therapy. Toward Clinical Trials of Glioma Treatment, Plenum Press, New York and London.
29. George-Nascimento, C., Gyenes, A., Halloran, S. M., Merryweather, J., Valenzuela, P., Steimer, K. S., Masiarz, F., and Randolph, A. (1988) Characterization of Recombinant Human Epidermal Growth Factor Produced in Yeast. Biochemistry 27, 792-802.
30. Harris, A. L. (1990) The Epidermal Growth Factor Receptor as a Target for Therapy. Cancer Cells 2, 321-323.
31. Hawthorne, M. F. (1993) The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer. Angew. Chem., Int. Ed. Engl. 32, 950-984.
32. Jain, R. K. (1989) Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies. J. Natl. Cancer Inst. 81, 570-576.
33. Kalofonos, H. P., Pawlikowska, T. R. Hemingway, A., Courtenay-Luck, N., Dhokia, B., Snook, D., Sivolapenko, G. B., Hooker, G. R., McKenzie, C. G., Lavender, P. J., Thomas, D. G. T., and Epenetos, A. A. (1989) Antibody Guided Diagnosis and Therapy of Brain Gliomas Using Radiolabeled Monoclonal Antibodies Against Epidermal Growth Factor Receptor and Placental Alkaline Phasphatase. J. Nucl. Med. 30, 1636-1645.
34. Kroin, J. F., and Penn, R. D. (1969) Implantable Pumps to Deliver Drugs Directly into CNS. Implications of The Blood Brain Barrier and Its Manipulation (E. A. Neuwelt, Ed.) Vol. 2, pp 107-261, Plenum Medical Book Co., New York and London.
35. Lee, Y., Bullard, D. E., Wikstrand, C. J., Zalutaky, M. R., Muhlbaier, L. H., and Bigner, D. B. (1987) Comparison of Monoclonal Antibody Delivery to Intracranial Glioma Xenografts by Intravenous and Intracarotid Administration. Cancer Res. 47, 1941-1946.
36. Liebert, M., Wahl, R. L., Lawless, G., McKeever, P. E., Taren, J. A., Beierwalters, W. H., and Brasswell, R. (1990) Direct Stereotactic Intracerebral Injection of Monoclonal Antibodies and Their Fragments: A Potential Approach to Brain Tumor Immunotherapy. Am. J. Physiol. Imaging 5, 55-59.
37. 125I-Labelled Epidermal Growth Factor-Dextran Conjugates. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science, Chapter V, p 428, Acta Univ. Upealiensis. Uppsala, Sweden.
38. Lund-Johansen, M., Bjerkvig, R. Humphrey, P. A., Bigner, S. H., Bigner, D. D., and Laerum, O.-D. (1990) Effects of Epidermal Growth Factor on Glioma Cell Growth, Migration and invasion in Vitro. Cancer Res. 50, 6039-6044.
39. Madrit, Y., Feigenbaum Langer, L., Brem, H., and Langer, R. (1991) New Directions if the Delivery of Drugs and Other Substances to the Central Nervous System. Semin. Pharmacol. 22, 299-324.
40. Mendelsohn, J. (1968) Growth Factor. Receptors as Targets for Antitumor Therapy with Monoclonal Antibodies. Prog. Allergy 46, 147-160.
41. Moditahedi, H., and Dean, C. (1991) The Receptor for EGF and Its Ligands: Expression, Prognostic Value and Target for Therapy in Cancer (Review). Int. J. Oncol. 4, 227-296.
42. Munson, P. J. (1984) Heterogeneous Receptors and Binding Curve Analysis in Neurobiology. Brain Receptor Methodologies. Part A: General Methods and Concepts. Amines and Acetylcholine (P. J. Marangos, I. C. Campbell, and R. M. Cohen, Eds.) pp 33-48, Academic Press, Inc., New York.
43. Neuwelt, E. A., Howieson, J., Frenkel, E. P., Specht, H. D., Weigel, R. Buchman. C. G., and Hill, S. A. (1986) Therapeutic Efficacy of Multiagent Chemotherapy with Drug Delivery Enhancement by Blood-Brain Bamer Modification in Glioblastoma. Neurosurgery 19, 573-582.
44. Neuwelt, E. A., Barnett, P. A., Hellström, I., Hellström, K. E., Beaumier, P., McCormick, C. I., and Weigel, R. M. (1988) Delivery of Melanoma-associated Immunoglobulin Monoclonal Antibody and Fab Fragments to Normal Brain Utilizing Osmotic Blood-Brain Barrier Disruption. Cancer Res. 48, 4725-4729.
45. Neuwelt, E. A., Barnett, P. A., Hellström, K. E., Hellström, I., McCormick, C. I., and Ramsey, F. L. (1994) Effect of Blood-Brain Barrier Disruption on Intact and Fragmented Monoclonal Antibody Localization in Intracerebral Human Lung Carcinoma Xenografts. J. Nucl. Med. 35, 1831-1841.
46. Nistér, M., Wedell, B., Betsholtz, C., Bywater, M., Pettersson, M., Westermark, B., and Mark, J. (1987) Evidence for Progressional Changes in The Human Malignant Glioma Line U-343MGa: Analysis of Karyotype and Expression of Genes Encoding the Subunit Chains of Platelet-derived Growth Factor. Cancer Res. 47, 4953-4960.
47. Oredipe, O. A., Barth, R. F., Rotaru, J. H., and Steplewski, Z. (1992) Lack of Effect of Recombinant Human Interferon-α2b on Expression of 17-1A Antigen on Human Colon Cancer Cells. Hybridoma 11, 607-615.
48. Ottensmeyer, F. P. (1984) Electron Spectroscopy Imaging: Parallel Energy Filtering and Microanalysis in the Fixedbeam Electron Microscope. J. Ultrastruct. Res. 88, 121-134.
49. Ottensmeyer, F. P., and Andrew, J. W. (1980) High Resolution Microanalysis of Biological Specimens by Electron Energy Loss Spectroscopy and by Electron Spectroscopic Imaging. J. Ultrastruct. Res. 72, 336-348.
50. Pollak, I. F., Randal, L. S., Kristofik, M. P., Kelly, R. H., Selker, R. G., and Vertosich, F. T., Jr. (1990) Responce of Malignant Glioma Cell Lines to Epidermal Growth Factor and Platelet-Derived Growth Factor in a Serum-free Medium. J. Neurosurg. 73, 106-112.
51. Reeves, J. R., Cooke, T. G. Fenton-Lee, D., McNicol A. M., Ozanne B. W., Richards, R. C., and Walsh, A. (1994) Localization of EGF Receptors in Frozen Tusue Sections by Antibody and Biotinylated EGF-based Techniques. J. Immanochem. Cytol. 42, 307-314.
52. Riva, P., Arista, A., Tison, V., Sturiale, C., Franceschi, G., Spinelli, A., Riva, N., Casi, M., Moscatelli, G., and Frattarelli, M. (1994) Intralesional Radioimmunotherapy of Malignant Gliomas. An Effective Treatment in Recurrent Tumors. Cancer 73, 1076-1082.
53. Sato, G. H., and Sato, J. D. (1960) Growth Factor Receptor Monoclonal Antibodies and Cancer Immunotherapy. J. Natl. Cancer Inst. 81, 1600-1601.
54. 125I-Iabelled Polypeptide, Epidermal Growth Factor. Nucl. Med. Biol. 18, 2451-246.
55. Snelling, I., Miyamoto, C. T., Bender, H., Brady, L. W., Steplewski, Z., Class, R., Emrich, J., and Rackover, M. A. (1995) Epidermal Growth Factor Receptor 425 Monoclonal Antibodies Radiolabelled with Iodine-125 in the Adjuvant Treatment of High-Grade Astrocytomas. Hybridoma 14, 111-114.
56. Soloway, A. H., Barth, R. F., and Carpenter, D. E., Eds. (1993) Advances of Neutron Capture Therapy, Plenum Press, New York.
57. Sorkin, A., Krolenko, S., Kurjavtceva, N., Lazebnik, J., Teslenko, L., Mangelsdorf Soderquist, A. and Nikolsky, N. (1991) Recycling of Epidermal Growth Factor Receptor Complexes in A431 Cells: Identification of Dual Pathways. J. Cell. Biol. 112, 55-63.
58. Spitzer, E., de Los Angeles, M., Perez, R. and Grosse, R. (1969) Binding Properties of Biotinylated Epidermal Growth Factor to Its Receptor on Cultured Cells and Tissue Sections. J. Cell. Biochem. 41, 47-56.
59. Thomas, G. D., Chappell, M. J., Dykes, P. W., Ramsden, D. B., Godfrey, K. R. Ellis, J. R. M., and Bradwell, A. R. (1990) Thearetical Considerations for Improving Tumor Targeting. Br. J. Cancer Suppl. 10, 70-73.
60. Todderund, G., and Carpenter, G. (1989) Epidermal Growth Factor the Receptor and Its Function. BioFactors 2, 11-15.
61. Tomalia, D. A. Naylor, A. M., and Goddard, W. A. III. (1990) Starburst Dendrimers: Molecular-Level Control of Size. Shape, Surface Chemistry. Topology, and Flexibility from Atoms to Macroscopic Matter. Angew. Chem., Int. Ed. Engl. 29, 138-175.
62. Torp, S. H., Helseth, E., Dalen, A., and Unsgaard, G. (1991) Epidermal Growth Factor Receptor Expression in Human Gliomas. Cancer Immunol. Immunother. 33, 61-64.
63. Tuzi, N. L., Venter, D. J., Kumar, S., Staddon, S. L., Lemoine, N. R. and Gullick, W. J. (1991) Expression of Growth Factor Receptors in Human Brain Tumors. Br. J. Cancer 63, 227-233.
64. Vaughan, A. T. M., Anderson, P., Dykes, P. W., Chapman, C. E., and Bradwell, A. R. (1987) Limitations to the Killing of Tumors Using Radiolabelled Antibodies. Br. J. Radiol. 60, 567-578.
65. Warren, G. (1990) Trawling for Receptors, Nature 346, 318-319.
66. Werner, M. H., Humphrey, P. A., Bigner, D. D., and Bigner, S. H. (1988) Growth Effects of Epidermal Growth Factor (EGF) and a Monoclonal Antibody Against the EGF Receptor on Four Glioma Cell Lines. Acta Neuropathol. 77, 196-201.
67. Westermark, B. (1977) Local Starvation for EGF Cannot Explain Density-Dependent Inhibition of Normal Human Glial Cells. Proc. Natl. Acad. Sci. USA. 74, 1619-1621.
68. Westermark, B., Magnusson, A., Heldin, C. H. (1982) Effect of Epidermal Growth Factor on Membrane Mobility and Cell Locomotion in Cultures of Human Clonal Glioma Cells. J. Neurosci. Res. 8, 491-507.
69. Yang, W., Barth, R. F., Carpenter, D. E., and Goodman, J. H. (1996) Enhanced Delivery of Boronophenylalanine to Brain Tumors for Neutron Capture Therapy by Means of Carotid Injection and Blood-Brain Barrier Disruption. Neurosurgery (in press).